{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:26:41Z","timestamp":1789298801875,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Struma ovarii is a rare form of mature cystic teratoma, with malignant transformation reported in approximately 5% to 10% of cases. Transformation into follicular thyroid carcinoma (FTC) is extremely uncommon; as a result, no standardized guidelines exist for treatment or prognosis for such cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 54-year-old woman with cholelithiasis presented with upper abdominal discomfort. A lower abdominal mass was incidentally detected during evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Transvaginal ultrasonography revealed a 12-cm multilocular cystic tumor in the right ovary. Magnetic resonance imaging and computed tomography findings suggested a mature cystic teratoma with potential for malignant transformation. Exploratory laparotomy was performed, and intraoperative frozen section analysis confirmed malignant transformation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient subsequently underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, para-aortic lymph node biopsy, and omentectomy. Histopathological examination revealed tumor cells demonstrating cribriform proliferation, accompanied by eosinophilic structures, extensive necrosis, and venous invasion. These findings supported the diagnosis of FTC arising within struma ovarii.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Postoperatively, the patient underwent routine follow-up, including serum thyroglobulin tests and imaging studies every 3 months. At 1 year, the patient showed no signs of tumor recurrence and remained in good clinical condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Malignant transformation of struma ovarii into FTC is an extremely rare condition and necessitates thorough histopathological evaluation for accurate diagnosis. This case highlights the diagnostic and therapeutic challenges associated with such tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044240","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T19:01:56Z","timestamp":1756494116000},"page":"e44240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Malignant transformation of struma ovarii into follicular thyroid carcinoma: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0257-0062","authenticated-orcid":false,"given":"Yasushi","family":"Umezaki","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasue","family":"Uriu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Okugawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Hashiguchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Saga University, Saga, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260406","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PGP.0b013e3181a27777","article-title":"Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread.","volume":"28","author":"Robboy","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R2-20260406","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0090-8258(03)00141-0","article-title":"Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.","volume":"89","author":"DeSimone","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R3-20260406","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PGP.0b013e31816a74c6","article-title":"Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.","volume":"27","author":"Roth","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20260406","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/105072501316973163","article-title":"Malignant struma ovarii: an unusual presentation.","volume":"11","author":"Checrallah","year":"2001","journal-title":"Thyroid"},{"key":"R5-20260406","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/his.15052","article-title":"Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.","volume":"84","author":"Neyrand","year":"2024","journal-title":"Histopathology"},{"key":"R6-20260406","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","article-title":"Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.","volume":"31","author":"Volante","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R7-20260406","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20260406","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","article-title":"Definition and management of radioactive iodine-refractory differentiated thyroid cancer.","volume":"2","author":"Schlumberger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-20260406","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.3390\/curroncol29120712","article-title":"Highly differentiated follicular carcinoma of ovarian origin: a systematic review of the literature.","volume":"29","author":"Giovannopoulou","year":"2022","journal-title":"Curr Oncol"},{"key":"R10-20260406","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"R11-20260406","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clon.2010.03.013","article-title":"Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.","volume":"22","author":"Smallridge","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R12-20260406","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a phase 3 trial.","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"R13-20260406","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13044-022-00132-6","article-title":"Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review.","volume":"15","author":"Leu\u0219tean","year":"2022","journal-title":"Thyroid Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:01:55Z","timestamp":1775455315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":13,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044240","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"2025-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}